1996

YEAR

099

In 1996, Lonza took an important transformational step into the field of biotechnology with the acquisition of Celltech Biologics, a leading manufacturer of therapeutic proteins for pharmaceutical customers. The Celltech acquisition brought Lonza two major facilities --  in Slough, UK and Portsmouth, New Hampshire USA  --  that remain vital hubs of the Mammalian Manufacturing (biologics) business unit.